콘텐츠로 건너뛰기
주식/증권 📈 긍정적

BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

요약

Bristol Myers Squibb's Growth Portfolio and pipeline support momentum, but generic headwinds and recent gains call for a cautious stance.